Cyclopharm Capital Raising
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Cyclopharm Limited is announcing an institutional placement to raise funds for its expansion and growth strategy in the USA. Proceeds will primarily support the growth of Technegas and other strategic priorities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Story so far
Earlier from Cyclopharm
- Cyclopharm Capital Raising Presentation
- Cyclopharm Business Update
- First USA Patients Imaged with Technegas
- S&P DJI Announces March 2024 Quarterly Rebalance
- Cyclopharm to Present at Euroz Hartleys Healthcare Forum
Later from Cyclopharm
- Cyclopharm Successfully Completes A$20.0 Million Placement
- TECHNEGAS Awarded US Pass-Through Reimbursemt Status
- Cyclopharm Presenting at Macquarie Emerging Leaders Conf
- USA Reimbursement Update for TECHNEGAS
- Cyclopharm completes oversubscribed Share Purchase Plan
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm